Your browser doesn't support javascript.
Assessing anxiety, depression and insomnia symptoms among Ebola survivors in Africa: A meta-analysis.
Acharibasam, Jeremiah W; Chireh, Batholomew; Menegesha, Hayelom G.
  • Acharibasam JW; Department of Community Health and Epidemiology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Chireh B; Saskatchewan Health Quality Council, Saskatoon, Saskatchewan, Canada.
  • Menegesha HG; College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia.
PLoS One ; 16(2): e0246515, 2021.
Article in English | MEDLINE | ID: covidwho-1388899
ABSTRACT

BACKGROUND:

During health disaster events such as the current devastating havoc being inflicted on countries globally by the SARS-CoV-19 pandemic, mental health problems among survivors and frontline workers are likely concerns. However, during such health disaster events, stakeholders tend to give more precedence to the socio-economic and biomedical health consequences at the expense of mental health. Meanwhile, studies show that regardless of the kind of disaster/antecedent, all traumatic events trigger similar post-traumatic stress symptoms among survivors, families, and frontline workers. Thus, our study investigated the prevalence of anxiety, depression and insomnia symptoms among survivors of the 2014-2016 Ebola virus disease that plagued the West African sub-region.

METHODS:

We systematically retrieved peer-reviewed articles published between 1970 and 2019 from seven electronic databases, including Google Scholar, MEDLINE, PsychInfo, PubMed, Scopus, Springer Link, Web of Science on Ebola and post-traumatic stress disorder symptoms. A comprehensive hand search complemented this literature search. Of the 87 articles retrieved, only 13 met the inclusion criteria for this meta-analysis.

RESULTS:

After heterogeneity, influence, and publication bias analysis, our meta-analysis pooled proportion effects estimates showed a moderate to a high prevalence of anxiety (14%; 99% CI 0.05-0.30), depression (15%; 99% CI 0.11-0.21), and insomnia (22%; 99% CI 0.13-0.36). Effect estimates ranging from (0.13; 99% CI 0.05, 0.28) through to (0.11; 99% CI 0.05-0.22), (0.15; 99% CI 0.09-0.25) through to (0.13; 99% CI 0.08-0.21) and (0.23; 99% CI 0.11-0.41) to (0.23; 99% CI 0.11-0.41) were respectively reported for anxiety, depression and insomnia symptoms. These findings suggest a significant amount of EVD survivors are struggling with anxiety, depression and insomnia symptoms.

CONCLUSION:

Our study provided the first-ever meta-analysis evidence of anxiety, depression, and insomnia symptoms among EVD survivors, and suggest that the predominant biomedical health response to regional and global health disasters should be complemented with trauma-related mental health services.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anxiety / Hemorrhagic Fever, Ebola / Depression / Sleep Initiation and Maintenance Disorders Type of study: Observational study / Prognostic study / Reviews Topics: Long Covid Limits: Humans Country/Region as subject: Africa Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: JOURNAL.PONE.0246515

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Anxiety / Hemorrhagic Fever, Ebola / Depression / Sleep Initiation and Maintenance Disorders Type of study: Observational study / Prognostic study / Reviews Topics: Long Covid Limits: Humans Country/Region as subject: Africa Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: JOURNAL.PONE.0246515